Abstract:Studies on associations between ataxia telangiectasia-mutated (ATM) polymorphisms and late radiotherapy-induced adverse events vary in clinical settings, and the results are inconsistent.We conducted the first meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to investigate the role of the ATM polymorphism rs1801516 in the development of radiotherapy-induced late fibrosis.We searched PubMed, Embase, Web of Science, and Chinese National Knowledge Infrastructure databases to identify studies that investigated the effect of the ATM polymorphism rs1801516 on radiotherapy-induced late fibrosis before September 8, 2015. Summary odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to assess the association between late fibrosis and the rs1801516 polymorphism. Subgroup analyses were conducted to evaluate the influence of clinical features on the genetic association. Tests of interaction were used to compare differences in the effect estimates between subgroups.The overall meta-analysis of 2000 patients from 9 studies showed that the minor allele of the rs1801516 polymorphism was associated with a significantly increased risk of developing late fibrosis (OR = 1.78, 95% CI: 1.07, 2.94), with high between-study heterogeneity (I = 66.6%, P = 0.002). In subgroup analyses, we identified that the incidence of late fibrosis was a major source of heterogeneity across studies. The OR for patients with a high incidence of late fibrosis was 3.19 (95% CI: 1.86, 5.47), in contrast to 1.09 (95% CI: 1.01, 1.17) for those with a low incidence. There was a significant difference in the effect estimates between the 2 subgroups (ratio of OR = 2.94, 95% CI 1.70, 5.08, P = 0.031).This meta-analysis supported previously reported effect of the ATM polymorphism rs1801516 on radiotherapy-induced late fibrosis. This finding encouraged further researches to identify more genetic polymorphisms that were predictive for radiotherapy-induced adverse events. In addition, we showed that the inconsistency of the associations seen in these studies might be related to variations in the incidence of late fibrosis in the patients. This suggested that future studies should consider the incidence of radiotherapy-induced adverse events when investigating radiosensitivity signature genes.

The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta‐Analysis of Different Measures of Risk

Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

Prevalence and Characterization of ATM Germline Mutations in Chinese BRCA1/2-negative Breast Cancer Patients

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis

Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis

Expression patterns of theATM gene in mammary tissues and their associations with breast cancer survival

ATM polymorphisms as risk factors for prostate cancer development

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

Association Between ATM Rs1801516 Polymorphism and Cancer Susceptibility: a Meta-Analysis Involving 12,879 Cases and 18,054 Controls

Ataxia-Telangiectasia Mutated (ATM) gene signaling pathways in human cancers and their therapeutic implications

Cancer risk according to type and location of ATM mutation in ataxia‐telangiectasia families

Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients

Breast cancer and ATM mutations: treatment implications

Single Nucleotide Polymorphism rs1801516 in Ataxia Telangiectasia-Mutated Gene Predicts Late Fibrosis in Cancer Patients After Radiotherapy: A PRISMA-Compliant Systematic Review and Meta-Analysis.

Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence data

Whole genome joint analysis reveals ATM :C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer

ATM Polymorphisms Are Associated with Radiosensitivity for Patients with Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiation Therapy

The landscape of ATM alteration in Chinese solid tumor patients.